Viral Hepatitis in Asia and the Pacific
Towards Elimination as a Public Health Threat
- 1st Edition - March 25, 2025
- Imprint: Academic Press
- Editors: Jing Sun, Polin Chan, Yoke Ling Chee
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 3 6 2 9 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 3 6 3 0 - 3
Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat documents the narratives, innovations, and scope of work in the Asia-Pacific region in starti… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteViral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat documents the narratives, innovations, and scope of work in the Asia-Pacific region in starting, consolidating, and moving towards the elimination of viral hepatitis. The Asia-Pacific region is disproportionately affected by viral hepatitis, accounting for two-thirds of the global burden. Countries from low-, middle- and high-income economies have adopted different strategies to address combating and eliminating viral hepatitis. The successful experiences of the Asia-Pacific region are valuable for other regions, especially the middle- and low-income countries moving towards the achievement of the 2030 goal of elimination.
Strategies discussed include integrated approaches, negotiating universal access to diagnostics, and treatment options, including vaccines. Content further covers the critical barriers to achieve the 2030 targets for elimination of viral hepatitis and how to overcome them. This is the perfect reference for all hepatology researchers and elimination policy advocates who are dedicated to joining the fight for the 2030 goal of the elimination of viral hepatitis as a public health threat.
- Focuses on the elimination of viral hepatitis as a global target through learning strategies and approaches in countries where hepatitis is most common
- Provides the “how” behind the elimination of viral hepatitis, including integrated approaches and shifts in science and policy
- Presents updated information from multiple countries on the challenges and strategies that can be used toward the WHO’s goal of eliminating viral hepatitis
Hepatology researchers Hepatitis elimination policy advocates
Viral Hepatitis in Asia and the Pacific: Towards Elimination as a Public Health Threat
Chapter 1 Epidemiology and response to viral hepatitis in Asia and the Pacific regions
Polin Chan, Tiara Mahatmi Nisa, Mohamed Amine Ghrabi, Kiyohiko Izumi, Amit Goel, Bharat Bhushan Rewari
Chapter 2 Towards elimination of viral hepatitis B and C in Australia
Jisoo A. Kwon, David C. Boettiger, David Newby
Chapter 3 Central pooled procurement and price negotiation: China’s strategies for affordable antiviral treatment of hepatitis B and C
Yihan Fu, Zhuoran Ma, Zhitao Wang, Shiyang Liu, Zhongdan Chen, Changsong Jiang, Jing Sun
Chapter 4 Efforts towards elimination of viral hepatitis in India
Ajeet Singh Bhadoria, Vineet Kumar Pathak, Pallav Bhattacharya, Pritam Roy, Gagandeep Grover, Pragya Pandey
Chapter 5 Hepatitis B Elimination in the Pacific Islands: Models of care delivery in Kiribati
Thomas Russell, David Hilmers, Caroline Lee, Alice Lee
Chapter 6 Government-led initiatives: a journey of enhancing hepatitis C treatment accessibility in Malaysia
Muhammad Radzi Abu Hassan, Huan Keat Chan, Han Yang Chung, Fazidah Binti Yuswan
Chapter 7 Viral hepatitis elimination in Mongolia
Gereltuya Dorj, Baatarkhuu Oidov, Gantuya Dorj, Undram Lkhagvaa, Nick Walsh, Amarjargal Choijoo, Unenbat Gurbadam, Javkhlan Jargalsaikhan, Baasandorj Erdenetsetseg
Chapter 8 Hepatitis B immunization
Xi Li, Sigrun Roesel
Chapter 9 South-South partnerships in developing affordable DAAs for low- and middle-income countries
Tilak Ramanaidu, Jean-Michel Piedagnel, Han Yang Chung, Wing Loong Cheong
Chapter 10 The ‘how’ of shifting a global paradigm: from dual to triple elimination of HIV, syphilis and viral hepatitis B
Polin Chan, Hui Zheng, Ailing Wang, Fuzhen Wang, Jinlin Hou, Zhihua Liu, Jidong Jia, Lai Wei, Yu Wang, Timothy Hallett, Shevanthi Nayagam, Xiaoyan Wang, Qian Wang, Fuqiang Cui, Daniel Low-Beer, Philippa Easterbrook, Zhuang Hui, Lawrence Everett Rodewald
Chapter 1 Epidemiology and response to viral hepatitis in Asia and the Pacific regions
Polin Chan, Tiara Mahatmi Nisa, Mohamed Amine Ghrabi, Kiyohiko Izumi, Amit Goel, Bharat Bhushan Rewari
Chapter 2 Towards elimination of viral hepatitis B and C in Australia
Jisoo A. Kwon, David C. Boettiger, David Newby
Chapter 3 Central pooled procurement and price negotiation: China’s strategies for affordable antiviral treatment of hepatitis B and C
Yihan Fu, Zhuoran Ma, Zhitao Wang, Shiyang Liu, Zhongdan Chen, Changsong Jiang, Jing Sun
Chapter 4 Efforts towards elimination of viral hepatitis in India
Ajeet Singh Bhadoria, Vineet Kumar Pathak, Pallav Bhattacharya, Pritam Roy, Gagandeep Grover, Pragya Pandey
Chapter 5 Hepatitis B Elimination in the Pacific Islands: Models of care delivery in Kiribati
Thomas Russell, David Hilmers, Caroline Lee, Alice Lee
Chapter 6 Government-led initiatives: a journey of enhancing hepatitis C treatment accessibility in Malaysia
Muhammad Radzi Abu Hassan, Huan Keat Chan, Han Yang Chung, Fazidah Binti Yuswan
Chapter 7 Viral hepatitis elimination in Mongolia
Gereltuya Dorj, Baatarkhuu Oidov, Gantuya Dorj, Undram Lkhagvaa, Nick Walsh, Amarjargal Choijoo, Unenbat Gurbadam, Javkhlan Jargalsaikhan, Baasandorj Erdenetsetseg
Chapter 8 Hepatitis B immunization
Xi Li, Sigrun Roesel
Chapter 9 South-South partnerships in developing affordable DAAs for low- and middle-income countries
Tilak Ramanaidu, Jean-Michel Piedagnel, Han Yang Chung, Wing Loong Cheong
Chapter 10 The ‘how’ of shifting a global paradigm: from dual to triple elimination of HIV, syphilis and viral hepatitis B
Polin Chan, Hui Zheng, Ailing Wang, Fuzhen Wang, Jinlin Hou, Zhihua Liu, Jidong Jia, Lai Wei, Yu Wang, Timothy Hallett, Shevanthi Nayagam, Xiaoyan Wang, Qian Wang, Fuqiang Cui, Daniel Low-Beer, Philippa Easterbrook, Zhuang Hui, Lawrence Everett Rodewald
- Edition: 1
- Published: March 25, 2025
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780443236297
- eBook ISBN: 9780443236303
JS
Jing Sun
Dr. Sun is the Professor for Pharmaceutical Policy of the Chinese Academy of Medical Sciences and Peking Union Medical College. Her research areas focus on pharmaceutical policy analysis and specialized in pharmaco-economics and pharmaco-epidemiology. She received her Ph.D. from the Graduate School of Medical Sciences at the University of Groningen of the Netherlands, MSc. of International Health Policy from London School of Economics of the UK, and Bachelor of Pharmaceutical Chemistry from Peking Medical University of China.
PC
Polin Chan
Dr Chan is the Regional Advisor for Hepatitis/HIV/STI in the World Health Organisation South-east Asia Regional Office (SEARO). She has served in countries and regions with WHO since 2005 in public health and communicable diseases prevention and control. Dr Chan graduated as a medical doctor from the University of Hong Kong, trained in women’s health, and in tropical medicine and epidemiology from the London School of Hygiene and Tropical Medicine.
YC
Yoke Ling Chee
Ms Chee is the Executive Director of Third World Network, a non-profit international policy research and advocacy organization involved in sustainable development issues. She is an international lawyer whose areas of expertise include the environmental, social and economic impacts of globalization, especially in countries of the South. She holds degrees from the University of Malaya (Malaysia) and Cambridge University (UK).
Read Viral Hepatitis in Asia and the Pacific on ScienceDirect